Cargando…

The new generation of messenger RNA (mRNA) vaccines against influenza

Today there are multiple types of flu vaccines. The emergence of nucleic acid technology used in vaccines against SARS-CoV-2 suggests its future application against this infection. Against influenza, two types of vaccines have been developed based on messenger RNA (mRNA): conventional or non-replica...

Descripción completa

Detalles Bibliográficos
Autor principal:	Reina, Jordi
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Sociedad Española de Enfermedades Infecciosas y Microbiología Clínica. Published by Elsevier España, S.L.U. 2023
Materias:	Review Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9315338/ https://www.ncbi.nlm.nih.gov/pubmed/35906174 http://dx.doi.org/10.1016/j.eimce.2022.07.006

Ejemplares similares

HIV and Messenger RNA (mRNA) Vaccine
por: Khalid, Khizer, et al.
Publicado: (2021)

Recent Advances in Messenger Ribonucleic Acid (mRNA) Vaccines and Their Delivery Systems: A Review
por: Yihunie, Wubetu, et al.
Publicado: (2023)

mRNA Vaccines against Flaviviruses
por: Wollner, Clayton J., et al.
Publicado: (2021)

Messenger RNAs bearing tRNA-like features exemplified by interferon alfa 5 mRNA
por: Díaz-Toledano, Rosa, et al.
Publicado: (2015)

Message in a bottle: mRNA vaccination for influenza
por: Shartouny, Jessica R., et al.
Publicado: (2022)

DNA and mRNA vaccination against allergies
por: Scheiblhofer, Sandra, et al.
Publicado: (2018)

mRNA, the beginning of a new influenza vaccine game
por: Pecetta, Simone, et al.
Publicado: (2022)

Self-assembled Messenger RNA Nanoparticles (mRNA-NPs) for Efficient Gene Expression
por: Kim, Hyejin, et al.
Publicado: (2015)

mRNA Vaccine Platform: mRNA Production and Delivery
por: Litvinova, V. R., et al.
Publicado: (2023)

mRNA as a Therapeutics: Understanding mRNA Vaccines
por: Oğuz, Ferdi, et al.
Publicado: (2022)

mRNA therapeutics: New vaccination and beyond
por: Wei, Huan-Huan, et al.
Publicado: (2023)

Enzymatic Protein Biopolymers as a Tool to Synthetize Eukaryotic Messenger Ribonucleic Acid (mRNA) with Uses in Vaccination, Immunotherapy and Nanotechnology
por: Urbina, Fabiola, et al.
Publicado: (2020)

mRNA-Based Vaccines
por: Kowalzik, Frank, et al.
Publicado: (2021)

Don’t blame the messenger: lessons learned for cancer mRNA vaccines during the COVID-19 pandemic
por: Morris, Van K., et al.
Publicado: (2022)

mRNA vaccines: the most recent clinical applications of synthetic mRNA
por: Kwon, Suji, et al.
Publicado: (2022)

Paired miRNA- and messenger RNA-sequencing identifies novel miRNA-mRNA interactions in multiple myeloma
por: Aass, Kristin Roseth, et al.
Publicado: (2022)

Identification of potential micro-messenger RNAs (miRNA–mRNA) interaction network of osteosarcoma
por: Xu, Keteng, et al.
Publicado: (2021)

RNA modification in mRNA cancer vaccines
por: Mei, Yingxue, et al.
Publicado: (2023)

Influenza Viruses: Innate Immunity and mRNA Vaccines
por: Lee, SangJoon, et al.
Publicado: (2021)

Rational development of a combined mRNA vaccine against COVID-19 and influenza
por: Ye, Qing, et al.
Publicado: (2022)

Self-Amplifying RNA Vaccines Give Equivalent Protection against Influenza to mRNA Vaccines but at Much Lower Doses
por: Vogel, Annette B., et al.
Publicado: (2018)

Petechiae and Desquamation of Fingers Following Immunization With BTN162b2 Messenger RNA (mRNA) COVID-19 Vaccine
por: Irvine, Nathaniel J, et al.
Publicado: (2021)

Evaluation of Messenger RNA From COVID-19 BTN162b2 and mRNA-1273 Vaccines in Human Milk
por: Golan, Yarden, et al.
Publicado: (2021)

A thermostable messenger RNA based vaccine against rabies
por: Stitz, Lothar, et al.
Publicado: (2017)

Messenger RNA metabolism of animal cells: possible involvement of untranslated sequences and mRNA-associated proteins
por: Greenberg,
Publicado: (1975)

Vesicular Rash Following Immunisation With BTN162b2 Messenger RNA (mRNA) COVID-19 Vaccine: Vaccine Related or Coincidence?
por: A. Rashid, Mohd Radzniwan, et al.
Publicado: (2022)

Messenger RNA vaccines against SARS-CoV-2
por: Topol, Eric J.
Publicado: (2021)

mRNA-Based Vaccine for COVID-19: They Are New but Not Unknown!
por: Chavda, Vivek P., et al.
Publicado: (2023)

Neo-Antigen mRNA Vaccines
por: Esprit, Arthur, et al.
Publicado: (2020)

COVID-19 mRNA vaccines
por: Huang, Qingrui, et al.
Publicado: (2021)

mRNA vaccine for cancer immunotherapy
por: Miao, Lei, et al.
Publicado: (2021)

The Delivery of mRNA Vaccines for Therapeutics
por: Nitika,, et al.
Publicado: (2022)

Vaccines against COVID-19: Priority to mRNA-Based Formulations
por: Pascolo, Steve
Publicado: (2021)

Challenges and Scientific Prospects of the Newest Generation of mRNA-Based Vaccines against SARS-CoV-2
por: Calina, Daniela, et al.
Publicado: (2021)

The advances of adjuvants in mRNA vaccines
por: Xie, Chunyuan, et al.
Publicado: (2023)

Delivery Strategies for mRNA Vaccines
por: Ramachandran, Sivakumar, et al.
Publicado: (2022)

Modifications of mRNA vaccine structural elements for improving mRNA stability and translation efficiency
por: Kim, Sun Chang, et al.
Publicado: (2021)

Advances in mRNA and other vaccines against MERS-CoV
por: Tai, Wanbo, et al.
Publicado: (2022)

mRNA Vaccine Protects against Zika Virus
por: Medina-Magües, Lex G., et al.
Publicado: (2021)

Role of Alternatively Spliced Messenger RNA (mRNA) Isoforms of the Insulin-Like Growth Factor 1 (IGF1) in Selected Human Tumors
por: Kasprzak, Aldona, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_ffrshpnhn0c0csribs4f0su6h2